Rita C.M. Pavanello

Universidade de São Paulo

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Mariz Vainzof

Universidade de São Paulo

Mayana Zatz

Universidade de São Paulo

Maria Rita Passos‐Bueno

Universidade de São Paulo

Suely Kazue Nagahashi Marie

Universidade de São Paulo

David Rapaport

Tel Aviv University

Manuel Cánovas

Instituto de Parasitología y Biomedicina "López - Neyra"

Mayana Zatz

Universidade de São Paulo

J M L Rocha

Universidade de São Paulo

Juliana Gurgel‐Giannetti

Universidade Federal de Minas Gerais

M Zatz

University of Michigan–Ann Arbor

Cooperative Institutions

Universidade de São Paulo

157

Instituto Biológico

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Universidade Federal de Minas Gerais

Universidade Brasil

Universidade Federal de São Paulo

Universidade Estadual Paulista (Unesp)

Hospital Israelita Albert Einstein

Hospital Universitário da Universidade de São Paulo

Universidade Estadual de Campinas (UNICAMP)

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population

Journal of the Neurological Sciences (1999)

Mariz Vainzof Maria Rita Passos-Bueno Rita C.M. Pavanello Suely Kazue Nagahashi Marie Acary Souza Bullé Oliveira

Limb-girdle muscular dystrophy

Alpha (finance)

10.1016/s0022-510x(99)00040-4

Cite

Citations (90)

Facioscapulohumeral (FSHD1) and other forms of muscular dystrophy in the same family: is there more in muscular dystrophy than meets the eye?

Neuromuscular Disorders (2002)

Maria Manuela O. Tonini Maria Rita Passos‐Bueno A. H. Cerqueira Rita C.M. Pavanello Mariz Vainzof

Facioscapulohumeral muscular dystrophy

Proband

Dysferlin

Dystrophy

Limb-girdle muscular dystrophy

Muscle weakness

10.1016/s0960-8966(02)00014-7

Cite

Citations (9)

P.4.12 Association of two mutations in the RYR1 gene in central core disease: Recessive or modifying effect?

Neuromuscular Disorders (2013)

Thais Cuperman Suzana Alcantara Manuel Cánovas Lídia Yamamoto Rita C.M. Pavanello

Central core disease

Congenital myopathy

10.1016/j.nmd.2013.06.450

Cite

Citations (0)

Is dystrophin always altered in Becker muscular dystrophy patients?

Journal of the Neurological Sciences (1995)

Mariz Vainzof Maria Rita Passos‐Bueno Rita C.M. Pavanello Mayana Zatz

Limb-girdle muscular dystrophy

10.1016/0022-510x(95)00104-a

Cite

Citations (12)

Nocturnal rhythm of growth hormone in Duchenne patients: Effect of different doses of mazindol and/or cyproheptadine

American Journal of Medical Genetics (1989)

Mayana Zatz Debora Rapaport Rita C.M. Pavanello J M L Rocha Mariz Vainzof

Abstract Human growth hormone (hGH) inhibition may be beneficial for Duchenne muscular dystrophy (DMD) patients and slow the rate of progression of the disease. The purpose of the present investigation was 1) to assess, before any therapeutic trial, the natural growth hormone (GH) rhythm during physiological sleep in DMD patients and in normal control boys of comparable age; 2) to evaluate the effect of different doses of two potential GH inhibitors on nocturnal GH secretion in DMD patients receiving mazindol (1–4 mg), cyproheptadine (4–8 mg), or both drugs. The results from the present investigation showed 1) wide variability in nocturnal GH secretion before medication; 2) no correlation between nocturnal GH concentration and height, age, bone age, L‐dopa provocative test, or Tanner staging; and 3) no consistent effect on GH release after mazindol, cyproheptadine therapy, or combined therapy.

Cyproheptadine

Mazindol

10.1002/ajmg.1320330408

Cite

Citations (12)

Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin

Neuromuscular Disorders (2014)

Mayana Zatz Rita C.M. Pavanello Monize Lazar Guilherme Lopes Yamamoto Naila Cristina Vilaça Lourenço

Nonsense mutation

mdx mouse

10.1016/j.nmd.2014.06.003

Cite